Biolex Therapeutics Adds Two Drug Development Executives to Accelerate Development of Locteron(R) in Hepatitis C

PITTSBORO, NC--(Marketwire - November 03, 2008) - Biolex Therapeutics, Inc. announced that Walker Long, M.D. has joined the Company as Chief Medical Officer and Vice President, Drug Development, and that Anne McKay has joined as Vice President, Regulatory Affairs. Each of these pharmaceutical executives brings a proven track record in drug development and complement the experienced management team already in place. The Company also announced that it has promoted Bipin Dalmia, Ph.D., MBA, to Senior Vice President, Business Development and Intellectual Property.